Updating a survey for medication error prevention

Journal of Oncology Pharmacy Practice

Volumn 8, Issue 4, 2002, Pages 105-117

  Grindrod, Kelly Anne ^a   Chambers, Carole R ^b   Hicks, Jolene ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c Tom Baker Cancer Institute   (Canada)

Author keywords

Canada; Chemotherapy; Literature review; Medication error; Medication error prevention

Indexed keywords

ANTINEOPLASTIC AGENT; VINBLASTINE; VINCRISTINE;

ARTICLE; CANADA; COCHRANE LIBRARY; DATA ANALYSIS; DRUG SAFETY; EMBASE; FEEDBACK SYSTEM; HEALTH CENTER; HEALTH SURVEY; HUMAN; IATROGENIC DISEASE; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDLINE; OUTCOMES RESEARCH; PHARMACY; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; REVIEW;

EID: 0036967354     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1191/1078155202jp098oa     Document Type: Article

References (38)

1. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999.
2. Phillips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health-Syst Pharm 2001; 58: 1835-41.
3. Beckwith MC, Tyler LS. Preventing medication errors with antineoplastic agents, Part I. Hosp Pharm 2000; 35: 511-25.
4. Beckwith MC, Tyler LS. Preventing medication errors with antineoplastic agents, Part II. Hosp Pharm 2000; 35: 732-47.
5. Bauman AN, Pedersen CA, Schommer JC, Griffith NL. Policies on documentation and disciplinary action in hospital pharmacies after a medication error. Am J Health-Syst Pharm 2001; 58: 1120-25.
6. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
7. Peartree Solutions. A situational analysis of human resources issues in the pharmacy profession in Canada. Executive summary. Hum Resour Dev Can. Government of Canada, May 2002.
8. Bridge Medical Medication error prevention program: checklist for hospitals. Bridge Medical [www.mederrors.com; accessed 10 May 2002.]
9. Medications safety self-assessment for community/ambulatory pharmacy. Institute for Safe Medication Practices [www.ismp.org.; accessed 10 May 2002].
10. Appendix A. Guidelines for liability and risk management. CSHP Off Publ [www.cshp.org; accessed 15 May 2002].
11. Ross TW, Wojdylo Jr. Identifying sources and reducing the potential for chemotherapy-related errors: mission impossible? JMCC 1997; 4: 528-36.
12. Mahoney CD, Berard CM, Simas EA, Lacroix S, Mahoney GM. Implementing a chemotherapy practice standard in an integrated health care system. Hosp Pharm 1998; 33: 954-60.
13. Fischer DS, Alfano M, Knobf MT, Donovan C, Beaulieu N. Improving the cancer chemotherapy use process. J Clin Oncol 1996; 12: 3148-55.
14. Gilbar PJ. Cancer chemotherapy: potential errors with external referrals. Aust J Hosp Pharm 1999; 29: 100-102.
15. Dunn EB, Wolfe JJ. Medication error reduction: the pharmacy technician's role. J Pharm Technol 1998; 14: 70-77.
16. Cohen MR. Drug product characteristics that foster drug-use-system errors. Am J Health-Syst Pharm [www.ashp.org/public/proad/mederror/pcoh.html; accessed 11 May 2002].
17. Argo AL, Cox KK, Kelly WN. The ten most common leathal medication errors in hospital patients. Hosp Pharm 2000; 35: 470-74.
18. Kelly WN. Pharmacy contributions to adverse medication events [www.ashp.org/public/proad/mederror/pkel.html; accessed 10 May 2002].
19. Gilmore CE, Suresky P. Development and implementation of a chemotherapy error-prevention policy. Hosp Pharm 1998; 33: 1213-18.
20. Massachusetts Coalition for the Prevention of Medical Errors. MHA best practice recommendations to reduce medication errors [www.mhalink.org/mcpme/mhabest∥acticecommendation.htm; accessed 17 October 2001].
21. Goldspiel BR, DeChristoforo R, Daniels CE. A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health-Syst Pharm 2000; 57(Suppl 4): S4-S9.
22. Berwick DM. Lessons from a novice. Presented at 'Let's Talk: Communicating Risk and Safety in Health Care'. Institute for Safe Medication Practices [www.ismp.org/pages/patientsafety.html; accessed 11 December 2001].
23. Hutcherson DA, Gammon DC. Preventing errors with antineoplastic agents: a pharmacist's approach. Hosp Pharm 1997; 32: 194-202, 209.
24. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician round and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-70.
25. US Pharmacopeia. Use caution-avoid confusion. USP Qual Rev 2001; 76: 1-6.
26. Leape LL. Preventing adverse drug events (for Understanding and Preventing Drug Misadventures Conference) [www.ashp.org/public/proad/mederrors/plea.html; accessed 5 November 2001].
27. Smetzer JL, Cohen MR. Lesson from the Denver medication error/criminal negligence case: look beyond blaming individuals. Hosp Pharm 1998; 33: 640-42, 645-46, 654-57.
28. Crane VS. New perspectives on preventing medication errors and adverse drug events. Am J Health-Syst Pharm 2000; 57: 690-97.
29. Kohn, LT. The Institute of Medication report on medical errors: overview and implications for pharmacy. Am J Health-Syst Pharm 2001; 58: 63-66.
30. US Pharmacist. Preventing medication error. Us Pharmacist Continuing Education [www.uspharmacist.com/newlook/ce/medErrors/lesson.cfm; accessed 12 February 2001].
31. Senders J. Theory and analysis of typical errors in a medical setting. Hosp Pharm 1993; 28: 505-508.
32. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med 1999; 159: 1939-45.
33. Schneider PJ. Pharmacists building a safer health system. Am J Health-Syst Pharm 2001; 58: 66-68.
34. Cohen MR, Anderson RW, Attilo RM, Green L, Muller RJ, Pruemer JM. Preventing medication errors in cancer chemotherapy. Am J Health-Syst Pharm 1996; 53: 737-46.
35. Olson KM. Medication errors: problems identified, but what is the solution? Crit Care Med 2002; 30: 1-3.
36. American Society of Health System Pharmacists. ASHP statement on reporting medical errors. Am J Health-Syst Pharm 2000; 57: 1531-32.
37. Trinkle R, Wu JK. Errors involving pediatric patients receiving chemotherapy: a literature review. Med Pediatr Oncol 1996; 26: 344-51.
38. Proulx S, Wilfinger R, Cohen MR. Medication error prevention: profiling one of pharmacies foremost advocacy efforts for advice on error prevention. Pharm Pract Manag Q 1997; 17: 1-9.